LSX Nordic Congress White

 

INTERNATIONAL STRATEGY, INVESTMENT, PARTNERING AND DEAL MAKING FOR NORDIC LIFE SCIENCE EXECUTIVE LEADERS


4th Annual Congress | Delivered Virtually



6 September - IPO Bootcamp
7-8 September - Main Days
6-17 September - Video Partnering

REGISTER NOW

DOWNLOAD BROCHURE

What is the LSX Nordic Congress?


The LSX Nordic Congress is the leading strategy, investment and partnering conference for the Nordic life science and healthcare industry. Now in its fourth year, the LSX Nordic Congress continues to help Nordic-based companies access local and international capital and strategic partners. 

It connects the community with regional and international investment and strategic partners to further growth, development and internationalisation.

It's a showcase platform for the region’s life sciences start-ups and technology innovators driving the future of healthcare.

The event provides the timeliest opportunity for private and public biotech, medtech and healthtech executives to engage with the stakeholders who can help their company thrive. 

In 2021, the event will be a virtual experience incorporating all the same features of the usual physical meeting, but spread across the week of the 6-10 September.

A second week of 1:1 video partnering has been added from 13-17 September.

LSX World Nordic

DOWNLOAD BROCHURE

The premier virtual experience for Nordic leaders in life sciences investment, technology, business and strategy

Key Speakers Include


Stephan Christgau, Managing Partner, Eir Ventures

Stephan Christgau

Managing Partner
Eir Ventures
Tahera Kan, VP Head of New Ventures & Transactions, Johnson & Johnson

Tahera Kan

VP Head of New Ventures & Transactions
Johnson & Johnson
Anna-Karin Edstedt Bonamy, CEO, Doctrin

Anna-Karin Edstedt Bonamy

CEO
Doctrin
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Bobby Soni, CBO, BII

Bobby Soni

CBO
BII
Christian Schetter, Managing Director, Arix Bioscience

Christian Schetter

Managing Director
Arix Bioscience
Mai-Britt Zocca, CEO, IO Biotech

Mai-Britt Zocca

CEO
IO Biotech
Søren Lemonius, Managing General Partner, Sunstone Life Science Ventures

Søren Lemonius

Managing General Partner
Sunstone Life Science Ventures
James Stamatis, Vice President, Head of Business Development and Acquisitions, AbbVie

James Stamatis

Vice President, Head of Business Development and Acquisitions
AbbVie
Petrina Knowles Gjelstrup, SVP People & Organisation, Novo Holdings

Petrina Knowles Gjelstrup

SVP People & Organisation
Novo Holdings
Anders Martin-Löf, CFO, Oncopeptides

Anders Martin-Löf

CFO
Oncopeptides
Nathalie ter Wengel, European Lead Worldwide Business Development, Pfizer

Nathalie ter Wengel

European Lead Worldwide Business Development
Pfizer

ALL SPEAKERS

700+
participants

150+
international investors & pharma

300+
c-suite company executives

2 weeks
international 1:1 video partnering

50+
company showcases

Host Partner


Nasdaq

Knowledge Partner


McKinsey and company

Gold Partners


Back Bay Life Science Advisors

Coulter Partners

Covington 300x150

Mintz

MSC Nordics

OTC Markets

Potter Clarkson 300x

TFS HealthScience

Vinge 300x150

Wildeco 300x

Silver Partners


BioInnovation Institute (BII)

NDA Group

Novo Nordisk 300x150

ProPharma Group

Bronze Partners


Cooley

DFIN

Kempen

Star

DOWNLOAD BROCHURE

Subscribe to hear speaker announcements, ticket offers and more